Ingela Maxvall is an experienced professional in the pharmaceutical industry, currently serving as Lab Team Lead for AstraZeneca's COVID-19 Assessment Lab in Sweden. From 1995 to 2011, they held various positions at AstraZeneca, progressing from Sr Research Scientist to Associate Principal Scientist, where they developed biomarker assays for clinical studies. Ingela holds a Master of Science in Molecular Biology from Umeå University and is currently pursuing a Master's in Environmental Risk Analysis at Linnéuniversitetet.
This person is not in the org chart
This person is not in any teams
This person is not in any offices